Continents are facing an apocalyptic pandemic that pose a mortal danger to millions of its citizens. This paper seeks to address the role of intellectual property law in addressing the problem of COVID-19 pandemic. We suggest that current international IP law regime and TRIPS Agreement do not...

European Union and the United States have experienced some of the most sever outbreaks of Covid-19. Paper investigates the EU and US divisions of power and suggest that due to the relative advantages and disadvantages of centralized federal responses and decentralized state responses, actions...

The Covid-19 Pandemic has been a singular event that affected health, economic situation and social cohesion around the world. The International Centre for Economic Analysis (ICEA), has organized the After the Pandemic Conference Series. The conferences in the series are devoted to analyzing...

We examine the diversification of administrative and procedural costs on patent stock using a large dataset from the European Patent Office with 15,000 firms for the period between 1995 and 2015. The results reveal that administrative and procedural costs are significant for firm-level patenting...

Lawyers and commercial contracting have been stressed by political uncertainty over the past four years. Brexit its uncertain outcome and the debate on the appropriate application of the frustration doctrine represent one of the most challenging issues for the current contract law scholarship...

This paper examines the contribution of administrative and procedural transaction costs to economic growth under common legal system. We show that administrative and procedural costs vary quite a lot even within the institutional environment sharing the common legal system. States with...

This paper seeks to quantify the functioning costs of Mexican property and contract law system for the sub-national panel of Mexican States and Mexico City and examine the respective effects of such increasing costs on sub-national paths of economic growth. Paper identifies a persistent negative...

In 2003, Denmark was the first industrialized country to outlaw the use of trans fats to tackle the harmful effects on human health. In 2009, Austria and Switzerland followed suit with the substantial restrictions on the use of trans fats. Other industrialized countries disfavored the ban and...

Do different pharmaceutical product liability regimes in different countries induce innovation or can they lead to potentially socially undesirable outcomes? We exploit the variation in pharmaceutical liability and litigation rules across firms in pharmaceutical industry and countries to explain...